NIH's biomedical imaging agency chooses UC-Irvine's Tromberg as new director

Bruce J. Tromberg, PhD, has been selected as the director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), one of the 27 agencies that make up the National Institutes of Health (NIH). Tromberg will oversee a 230-person staff and a portfolio of 800 grants dedicated to imaging and technologies to improve the detection, treatment and prevention of disease.

“Bruce brings substantial experience in biophotonics and demonstrated his commitment to state-of-the-art imaging and bioengineering technologies through his research and leadership on numerous advisory committees, including the NIBIB National Advisory Council,” said Francis S. Collins, MD, PhD, director of NIH, in a prepared statement. “We look forward to having him join the NIH to guide NIBIB in the development and testing of biotechnologies to advance human health.”

Tromberg is currently a professor at the University of California, Irvine in biomedical engineering and surgery. He also directs the university’s Beckman Laser Institute and Medical Clinic. He will join NIH in 2019.

In his 30-year career, Tromberg has participated in numerous NIH-supported research projects, including 20 years as the principle investigator for the Laser Microbeam and Medical Program. He also served on the NIBIB National Advisory Council from 2012 to 2016.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.